Medical School or Training
Universidad de Panama, 1984
Baylor College of Medicine, Internal Medicine, TX, 1993
Baylor College of Medicine, Internal Medicine, TX, 1994
Internal Medicine Nephrology, Johns Hopkins School of Medicine, 1997
Dr. Milagros (Millie) Samaniego received her M.D. degree from the University of Panama. She was an intern and resident in internal medicine at Baylor College of Medicine in Houston, TX where she served as Chief Resident from 1993-1994. In 1994, Dr. Samaniego started post-doctoral training in Nephrology and Immunopathology at the Johns Hopkins School of Medicine in Baltimore, MD. During her fellowship, Dr. Samaniego received the ASTP-Sandoz Fellowship Award in Transplantation in addition to grant support from the Maryland Chapter of the National Kidney Foundation. Until 2006, she was supported by a Scientist-Development Grant of the American Heart Association.
Following her fellowship, she joined the faculty of the Johns Hopkins Divisions of Nephrology and Immunopathology rising through the ranks from Research Associate to Assistant Professor. In 2004, Dr. Samaniego moved to the University of Wisconsin-Madison, and joined the Section of Nephrology as Associate Professor and Transplant Physician.
In 2009, Dr. Samaniego joined the faculty of the University of Michigan Medical School, where she is the Medical Director of the Kidney and Kidney-Pancreas Transplant Program, and the Transplant Nephrology Fellowship. She is a Professor of Medicine in the Instructional (tenure) track.
Dr. Samaniego is former Associate Editor of the American Journal of Transplantation, has served on the Basic Science, Education and the Women’s Health Committees of the American Society of Transplantation. She has also participated as lecturer (since 2004) and Chair of the AST Fellows Symposium since 2009, and the 2009-2010 AST Winter Symposium. She has been an abstract reviewer for the American Congress of Transplantation for the past 14 years. She has been a post-hoc-reviewer for all major transplantation journals since 2000.
Dr. Samaniego’s clinical and research interests focus on experimental and clinical antibody-mediated rejection, desensitization protocols, and the care of highly sensitized patients.